Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3
3(75.0%)
Phase 1
1(25.0%)
4Total
Phase 3(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07457294Phase 3Not Yet Recruiting

1% Clascoterone Cream for the Treatment Acne Vulgaris

Role: lead

NCT07080931Phase 3Recruiting

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

Role: lead

NCT06403501Phase 3Recruiting

Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris

Role: lead

NCT06454708Phase 1Completed

Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

Role: lead

All 4 trials loaded